William Oldaker - Curasan AG Insider

Curasan AG -- Germany Stock  

EUR 1.24  0.01  0.8%

Independent Director

Mr. William Oldaker is Independent Director of Neuralstem Inc. since April 12 2007. Mr. Oldaker is a founder and partner in the Washington D.C. law firm of Oldaker Group LLC. Prior to founding the firm in 1993 Mr. Oldaker was a partner in the Washington office of the law firm of Manatt Phelps and Phillips from 1987 to 1993. In 2004 Mr. Oldaker was a founder of Washington First Bank in Washington D.C. and serves as a member of the board of directors. He previously served as a director of Century National Bank from 1982 until its acquisition in 2001
Age: 72  Director Since 2007      
49 60 2740 9000  http://www.curasan.de
Oldaker was appointed by President Clinton to serve as a commissioner on the National Bioethics Advisory Commission, a post he held until 2001. He is a member of the Colorado, D.C. and Iowa Bar Associations, the Bar Association for the Court of Appeals, D.C., and the Bar of the United States Supreme Court. He is also a partner in The National Group, a consulting firm.

William Oldaker Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (15.0) % which means that it has lost $15.0 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (35.94) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 427 K in total debt with debt to equity ratio (D/E) of 6.0 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Curasan AG has Current Ratio of 1.29 suggesting that it is in a questionable position to pay out its financial obligations in time and when they become due.

Similar Executives

Entity Summary

curasan AG develops, produces, and markets medical solutions worldwide. Curasan AG (CUR) is traded on Frankfurt Stock Exchange in Germany. It is located in Kleinostheim, and employs 33 people.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Curasan AG to your portfolio

Top Management

Curasan AG Leadership Team
William Oldaker, Director
David Castaneda, Executive
Stanley Westreich, Director
Karl Johe, Chairman
Scott Ogilvie, Director
I Garr, CEO
Catherine Sohn, Director, Ph.D
Richard Garr, CEO
Richard Daly, CEO, MBA
Sandford Smith, Director
Jonathan Jones, CFO

Stock Performance

Curasan AG Performance Indicators